Hematological profile of rats in experimental diclofenac-induced hepatitis

V.А. Gryshchenko


Sodium diclophenac belongs to a group of nonsteroidal anti-inflammatory drugs, which is indicated for inflammatory, degenerative and traumatic lesions system of the skeleton, muscles and connectives tissues. The features of changes in hematological (above all, morphological) indices in Wistar line rats for experimental reproduction of toxic hepatitis at oral introduction of diclofenac sodium in a dose of 12.5 mg / kg of body weight (once a day, within 14 days) were investigated. This rats demonstrated the development of chronic inflammatory process in liver that was characterized by reactive leukocytosis (an increase in the number of leukocytes by a factor of 3), neutrophil right shift, monocytopenia (a decrease in the number of monocytes by a factor of 2.6) together with compensatory lymphocytosis, high values of ESR (by a factor of 5.5), and thymol test (by a factor of 2.9). However, erythrocytopenia (a decrease in the number of erythrocytes by 44 %) – which is a sign of anemia development – was revealed in animals under the experimental toxic hepatitis. Besides it, the hemoglobin content was in the range of normal values that was an evidence of a compensatory role of red bone marrow in the maintaining homeostasis of the respiratory function of blood. There were no changes in blood rheology that was indicated by definite stability of the hematocrit value in sick animals. We registered the development of chronic inflammatory process and anemia in rats caused by experimental reproduction of toxic liver damage by oral introduction of sodium diclofenac. 


leukocyte formula;ESR;hemoglobin;blood;laboratory rats;experimental toxic hepatitis;sodium diclofenac

Full Text:



Abd Elazem, M.A., Seham, Y. Abo-Kora (2015). Adverse effects of diclofenac potassium and dexamethason on some hematobiochemical and immunological parameters in Egyptian goat bucks. Journal of American Science, 11(7), 92–99. DOI: 10.7537/marsjas110715.11

Ahmad, I., Quresh, T., Sadique, U., Khan, S.A., Ahmed, S. et al. (2013). Hematological effects of diclofenac sodium in goat. Journal of Animal and Plant Sciences, 23(1), 103–107.

Basavraj, S.B., Fefar, D.T., Prajapati, K.S., Jivani, B.M., Thakor, K.B. et al. (2012). Haematobiochemical alterations induced by diclofenac sodium toxicity in Swiss albino mice. Veterinary World, 5(7), 417–419. DOI: 10.5455/vetworld.2012.417-419

Calderon, R.M., Cubeddu, L.X., Goldberg, R.B., Schiff, E.R. (2010). Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. Mayo Clinic Proceedings, 85, 349–356. DOI: 10.4065/mcp.2009.0365.

Chang, C.Y., Schiano, T.D. (2007). Review article: drug hepatotoxicity. Alimentary Pharmacology & Therapeutics, 25(10), 1135–1351. DOI: 10.1111/j.1365-2036.2007.03307.x

Cole, H.L., Pennycook, S., Hayes, P.C. (2016). The impact of proton pump inhibitor therapy on patients with liver disease. Alimentary Pharmacology & Therapeutic, 44(11–12), 1213–1223. DOI: 10.1111/apt.13827.

Donnelly, M.C., Davidson, J.S., Martin, K., Baird, A., Hayes, P.C., Simpson, K.J. (2017). Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look-Back Study). Alimentary Pharmacology & Therapeutics, 45(6), 833–843. DOI: 10.1111/apt.13943

El-Maddawy, Z.Kh., El-Ashmawy, I. (2013). Hepato-Renal and Hematological Effects of Diclofenac Sodium in Rats. Global Journal of Pharmacology, 7(2), 123–132. DOI: 10.5829/idosi.gjp.2013.7.2.72171

Fabbrini, E., Magkos, F. (2015). Hepatic steatosis as a marker of metabolic dysfunction. Nutrients, 7(6), 4995–5019. DOI: 10.3390/nu7064995

Gan, T.J. (2010). Diclofenac: an update on its mechanism of action and safety profile. Current Medical Research and Opinion, 26: 1751–1731. DOI: 10.1185/03007995.2010.486301

Gariani, K., Ryu, D., Menzies, K. J., Yi, H.-S., Stein, S. et al. (2017). Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease. Journal of Hepatology, 66(1), 132–141. DOI: 10.1002/hep.28245

Gryshchenko, V.A. (2017). Biochemical properties of the plasma of rats with the experimentally induced hepatitis after oral administration of sodium diclofenac, Regulatory Mechanisms in Biosystems, 191–196. DOI: 10.15421/021730 (in Ukrainian).

Gryshchenko, V.A., Tomchuk, V.A. (2016). Methods of functional state of the liver: Guidelines, Kyiv, CB "Komprynt" (in Ukrainian).

Harirforoosh, S., Asghar, W., Jamali, F. (2013). Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 16(5), 821–847. DOI: 10.18433/J3VW2F

Kostyuk, S.S. (2014). Leucogram blood of white rats under the influence of gamma irradiation on the back-graund of pyridoxine. Journal of Medical and Biological Problems, 4(3:115), 56–59 (in Ukrainian).

Lucena, M.I., Andrade, R.J., Martinez, C., Ulzurrun, E., Garcı́a-Martı́n, E. et al. (2008). Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury. Hepatology (Baltimore, Md), 48(2), 588–596.

Melnychuk, D.O., Gryshchenko, V.A. (2016). Method modeling of toxic hepatitis. Patent UA, 105657 (in Ukrainian).

Okudo, J., Anusim, N. (2016). Hepatotoxicity due to clindamycin in combination with acetaminophen in a 62-year-old african american female: a case report and review of the literatureю. Case Reports in Hepatology, 1–5. DOI: 10.1155/2016/2724738

Orinya, O.A., Adenkola, A.Y., Ogbe, R.J. (2016). Haematological and biochemical studies on the effect of diclofenac sodium on Wistar Rattus norvegicus. International Journal of Biological and Chemical Sciences, 10(5), 2231–2242. DOI: 10.4314/ijbcs.v10i5.23

Ragbetli, С., Aydinlioglu, А., Kara, М., Ragbetli, М.С., Ilhan, F. (2009). Effects of Diclofenac Sodium on the Rat Liver in Postnatal Period. Journal of Animal and Veterinary Advances, 8(9), 1761–1764.

Rahmani, S., Asgary, S., Askari, G., Keshvari, M., Hatamipou, M., Feizi, A., Sahebkar, A. (2016). Treatment of Non-alcoholic Fatty Liver Disease with Curcumin: A Randomized Placebo-controlled Trial. Phytotherapy Research, 30(9), 1540–1548.

Rykalo, N.A., Yarovenko, L.A. (2015). Features of reparative regeneration of the liver tissue in rats during experimental tetrachloromethanic and alcoholic hepatitis. Pathologia, 1(33), 84–89 (in Ukrainian).

Schapira, D., Bassan, L., Nahir, A.M., Scharf, Y. (1986). Diclofenac-induced hepatotoxicity. Postgraduate medical Journal, 62, 63–65. DOI: 10.1136/pgmj.62.723.63

Serdyukov, Y.K., Lytvynenko, O.N., Gryshchenko, V.A. (2008). Pathologo anatomical and histological changes are in liver of rats at a medicamentous hepatitis. Modern Problems of Toxicology, 2, 63–65. (in Ukrainian).

Syed, N.I., Zehra, F., Syed, A.A., Karim, S., Khan, F.Z. (2012). Comparing the effects of salts of diclofenac and alminoprofen with aspirin on serum electrolytes, creatinine and urea levels in rabbits. Pakistan Journal of Pharmaceutical Sciences, 25(4), 777–782.

Teschke, R., Schulze, J., Schwarzenboeck, A., Frenzel, C. (2013). Herbal hepatotoxicity: suspected cases assessed for alternative causes. European J. Gastroenterology & Hepatology, 25(9), 1093–1098. DOI: 10.1097/MEG.0b013e3283603e89

Tomic, Z., Milijasevic, B., Sabo, A., Dusan, L., Jakovljevic, V. et al. (2008). Diclofenac and ketoprofen liver toxicity in rat. European Journal of Drug Metabolism and Pharmacokinetics, 33(4), 253–260. doi:10.1007/BF03190881

Tomov T., Velichkova-Markova, S. (1983). Effect of Feloran (diclofenac sodium) on the oxidative phosphorylation of rat liver mitochondria. Acta Physiol Pharmacol Bulg., 9(1), 66–72.

Vlizlo, V.V., Fedoruk, R.S., Ratych, I.B. (2012). Laboratory methods of investigation in biology, stock-breeding and veterinary. Spolom, Lviv (in Ukrainian).

DOI: http://dx.doi.org/10.15421/2017_52

Article Metrics

Metrics Loading ...

Metrics powered by PLOS ALM


  • There are currently no refbacks.

Since April 2018 Journal changed the editorial policy and starts to be published exclusively in English, and changed its main site into www.ujecology.com


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

© 2017 Ukrainian Journal of Ecology. ISSN 2520-2138